当前位置: 首页? 政策法规? 国外法规? 美国撤销林可霉素等兽药的使用

美国撤销林可霉素等兽药的使用

扫描二维 分享好友和朋友圈
放大字体缩小字体2017-02-27 09:11:30 来源9a href="https://www.federalregister.gov/documents/2017/02/24/2017-03595/new-animal-drugs-withdrawal-of-approval-of-new-animal-drug-applications" target="_blank" rel="nofollow">美国食品药品管理局浏览次数9span id="hits">4289
核心提示?017??4号,美国食品药品管理局发布法规,撤销了林可霉素、维及霉素、泰乐菌素等在内?0种兽药的使用、/div>
发布单位
美国食品药品管理局
美国食品药品管理局
发布文号 82 FR 11509
发布日期 2017-02-24 生效日期 2017-02-24
有效性状?/th> 废止日期 暂无
属?/th> 法规 专业属?/th> 其他
备注 2017??4号,美国食品药品管理局发布法规,撤销了林可霉素、维及霉素、泰乐菌素等在内?0种兽药的使用,法规自2017??4号实施,药品生产商应及时调整某些兽药的使用范围,此法规的发布符合了FDA一直倡导的合理使用抗生素的理念、/td>

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notification of withdrawal.

SUMMARY:

The Food and Drug Administration (FDA) is withdrawing approval of 18 new animal drug applications (NADAs) and 2 abbreviated new animal drug applications (ANADAs). These withdrawals of approval of NADAs and ANADAs for antimicrobial drugs of importance to human medicine that are administered to food-producing animals in medicated feed are being made because the products are no longer manufactured or marketed. These actions are consistent with the FDA Center for Veterinary Medicine's initiative for the Judicious Use of Antimicrobials.

DATES:

Withdrawal of approval is effective February 24, 2017.

FOR FURTHER INFORMATION CONTACT:

Sujaya Dessai, Center for Veterinary Medicine (HFV-212), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-402-5761,sujaya.dessai@fda.hhs.gov.

SUPPLEMENTARY INFORMATION:

FDA is withdrawing approval of 18 NADAs and 2 ANADAs. These applications were identified as being affected by guidance for industry (GFI) #213, New Animal Drugs and New Animal Drug Combination Products Administered in or on Medicated Feed or Drinking Water of Food-Producing Animals: Recommendations for Drug Sponsors for Voluntarily Aligning Product Use Conditions With GFI #209, December 2013 (http://www.fda.gov/downloads/AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/UCM299624.pdf). Their withdrawal of approval is consistent with the FDA Center for Veterinary Medicine's initiative for the Judicious Use of Antimicrobials.

Approval of the following applications for new animal drugs administered in medicated feed is being voluntarily withdrawn at the sponsors' requests because these products are no longer manufactured or marketed:

File No. Product name Sponsor
044-820 LINCOMIX (lincomycin)/AMPROL PLUS (amprolium and ethopabate) Zoetis Inc. 333 Portage St. Kalamazoo, MI 49007 (Zoetis Inc.).
044-972 LINCOMIX (lincomycin)/COYDEN (clopidol) Zoetis Inc.
047-261 LINCOMIX (lincomycin)/DECCOX (decoquinate) Zoetis Inc.
047-262 LINCOMIX (lincomycin)/DECCOX (decoquinate) Zoetis Inc.
048-954 LINCOMIX (lincomycin)/ZOAMIX (zoalene) Zoetis Inc.
091-513 STAFAC (virginiamycin) Type A Medicated Article Phibro Animal Health Corp., GlenPointe Centre East, 3d floor, 300 Frank W. Burr Blvd., Suite 21, Teaneck, NJ 07666 (Phibro Animal Health Corp.).
092-482 LINCOMIX (lincomycin)/COBAN (monensin) Zoetis Inc.
093-106 LINCOMIX (lincomycin)/ROBENZ (robenidine) Zoetis Inc.
101-689 LINCOMIX (lincomycin)/AVATEC (lasalocid) Zoetis Inc.
122-481 STAFAC (virginiamycin)/COBAN (monensin) Phibro Animal Health Corp.
122-608 STAFAC (virginiamycin)/AVATEC (lasalocid) Phibro Animal Health Corp.
122-822 STAFAC (virginiamycin)/AMPROL PLUS (amprolium and ethopabate) Phibro Animal Health Corp.
137-537 LINCOMIX (lincomycin)/BIO-COX (salinomycin) Zoetis Inc.
138-792 TYLAN (tylosin)/RUMENSIN (monensin)/MGA (melengestrol acetate) Zoetis Inc.
138-828 STAFAC (virginiamycin)/BIO-COX (salinomycin) Phibro Animal Health Corp.
138-904 TYLAN (tylosin)/BOVATEC (lasalocid)/MGA (melengestrol acetate) Zoetis Inc.
141-110 STAFAC (virginiamycin)/COBAN (monensin) Phibro Animal Health Corp.
141-150 STAFAC (virginiamycin)/AVATEC (lasalocid) Phibro Animal Health Corp.
200-092 STAFAC (virginiamycin)/SACOX (salinomycin) Huvepharma EOOD, 5th Floor, 3A Nikolay Haytov Str., 1113 Sophia, Bulgaria (Huvepharma EOOD).
200-093 LINCOMIX (lincomycin)/SACOX (salinomycin) Huvepharma EOOD.

Therefore, under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, and in accordance with ?514.116 Notice of withdrawal of approval of application (21 CFR 514.116), notice is given that approval of NADAs 044-820, 044-972, 047-261, 047-262, 048-954, 091-513, 092-482, 093-106, 101-689, 122-481, 122-608, 122-822, 137-537, 138-792, 138-828, 138-904, 141-110, 141-150, 200-092, and 200-093, and all supplements and amendments thereto, is hereby withdrawn, effective February 24, 2017.

Elsewhere in this issue of the Federal Register, FDA is amending the animal drug regulations to reflect the voluntary withdrawal of approval of these applications.

Dated: February 17, 2017.

Leslie Kux,

Associate Commissioner for Policy.

地区9/font>美国
标签9/font>兽药
食品伙伴网提供标准法规解读、舆情监控、合规咨询、申报注册等服务、br/>电询?535-2129301
QQ?891238009
食品标法? border=
实时把握 食品标法动?/span>
请扫码关?span class="color2">食品标法圇/span>

声明9/p>

凡本网所有原?编译文章及图片、图表的版权均属食品伙伴网所有,如要转载,需注明“信息来源:食品伙伴网”、br> 凡本网注明“信息来源:XXX(非食品伙伴网)”的作品,均转载自其他媒体,转载目的在于传递更多的信息,并不代表本网赞同其观点和对其真实性负责、br> 邮箱:law#www.sqrdapp.com(发邮件时请?换成@ QQ?39307733

[ 政策法规搜索] [ 加入收藏] [ 告诉好友] [ 打印本文] [ 关闭窗口]


按分类浏觇/strong>
推荐国外法规
点击排行
按国家或地区浏览

法规中心 关于我们 广告业务 联系我们 信息服务

Processed in 0.053 second(s), 10 queries, Memory 4.48 M
Baidu
map